Metis Global Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Sell
133,464
-4,207
-3% -$486K 0.39% 35
2025
Q4
$14.5M Sell
137,671
-4,967
-3% -$466K 0.34% 44
2025
Q3
$12M Sell
142,638
-8,983
-6% -$740K 0.28% 51
2025
Q2
$12M Sell
151,621
-16,415
-10% -$1.3M 0.31% 47
2025
Q1
$15.1M Buy
168,036
+15,964
+10% +$1.49M 0.42% 38
2024
Q4
$15.1M Buy
152,072
+2,782
+2% +$287K 0.46% 32
2024
Q3
$17M Buy
149,290
+4,298
+3% +$511K 0.53% 27
2024
Q2
$18M Buy
144,992
+1,440
+1% +$185K 0.62% 25
2024
Q1
$18.9M Sell
143,552
-2,022
-1% -$249K 0.69% 23
2023
Q4
$15.9M Buy
145,574
+16,730
+13% +$1.74M 0.63% 24
2023
Q3
$13.3M Buy
128,844
+17,239
+15% +$1.86M 0.64% 23
2023
Q2
$12.9M Buy
111,605
+1,904
+2% +$216K 0.69% 22
2023
Q1
$11.7M Buy
109,701
+24,307
+28% +$2.62M 0.75% 19
2022
Q4
$9.47M Buy
85,394
+32,377
+61% +$3.31M 0.84% 18
2022
Q3
$4.57M Buy
53,017
+3,291
+7% +$294K 0.74% 20
2022
Q2
$4.53M Buy
49,726
+7,445
+18% +$660K 0.73% 22
2022
Q1
$3.47M Buy
42,281
+17,881
+73% +$1.41M 0.42% 33
2021
Q4
$1.87M Buy
+24,400
New +$1.94M 0.52% 40

Other funds holding MRK

Metis Global Partners's MRK Position: Q1 2026 in Review

Metis Global Partners reduced its Merck (MRK) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 133,464 shares worth $16.1M. The position accounts for 0.39% of the portfolio, ranked #35.

Metis Global Partners first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $18.9M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Metis Global Partners held 133,464 shares of Merck worth $16.1M as of Q1 2026.
  • Metis Global Partners sold 4,207 Merck shares in Q1 2026, an estimated $486K.
  • Merck made up 0.39% of Metis Global Partners's portfolio in Q1 2026, its #35 holding.
  • Metis Global Partners first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Metis Global Partners's Merck position peaked at $18.9M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.